Impact of a Gluten-Free Diet on Quality of Life and Health Perception in Patients with Type 1 Diabetes and Asymptomatic Celiac Disease

Author(s):  
Daniel I Weiman ◽  
Farid H Mahmud ◽  
Antoine B M Clarke ◽  
Esther Assor ◽  
Charlotte McDonald ◽  
...  

Abstract Context Celiac disease (CD) is a common comorbidity seen in patients with type 1 diabetes (T1D) and is frequently asymptomatic. As chronic conditions requiring significant lifestyle changes, there are limited reports assessing changes in health-related quality of life (HRQoL) during transition to a gluten-free diet (GFD) in patients with both T1D and who are asymptomatic for CD. Objective To prospectively assess HRQoL and health perception in children and adults with T1D and asymptomatic CD after randomization to GFD versus usual diet. Design, Setting, and Participants Patients with T1D aged 8-45 years without CD symptoms were serologically screened for CD, with positive results confirmed with intestinal biopsy. Participants were randomized in an open-label fashion to a GFD or gluten-containing diet (GCD) for 12 months. Generic and diabetes-specific HRQoL and self-perceived wellness (SPW) were assessed longitudinally. Results 2,387 T1D patients were serologically screened. CD was biopsy-confirmed in 82 patients and 51 participants were randomized to a GFD (N=27) or GCD (N=24). Excellent adherence to the assigned diets was observed. Overall, no changes in generic (P=0.73) or diabetes-specific HRQoL (P=0.30), or SPW (P=0.41) were observed between groups over 12 months. HemoglobinA1c (HbA1c) and GI symptoms were consistent predictors of HRQoL and SPW. Conclusions HRQoL and SPW were not significantly impacted by the adoption of a GFD over 12 months, but worsened with symptom onset and increased HbA1c. Our findings indicate that transition to a GFD can be made successfully in this population without adversely impacting quality of life.

2016 ◽  
Vol 179 ◽  
pp. 131-138.e1 ◽  
Author(s):  
Anna Pham-Short ◽  
Kim C. Donaghue ◽  
Geoffrey Ambler ◽  
Sarah Garnett ◽  
Maria E. Craig

2020 ◽  
Vol 3 (Supplement_1) ◽  
pp. 64-65
Author(s):  
P M Miranda ◽  
G H Rueda ◽  
N Calo ◽  
C Seiler ◽  
Z Punthakee ◽  
...  

Abstract Background Patients with type 1 Diabetes Mellitus (T1DM) often suffer with gastrointestinal (GI) symptoms, such as abdominal pain, bloating, early satiety, nausea and vomiting. T1DM patients are at a higher risk to develop celiac disease, and those patient with both disorders benefit from a gluten-free diet (GFD). However, it is unknown whether GFD has any benefit in patients with T1DM without celiac disease who present with upper GI symptoms. Aims To investigate the role of GFD in the management of moderate to severe dyspeptic symptoms in non-celiac patients with T1DM. Methods We enrolled adult T1DM patients, in whom celiac disease was ruled out by serology and/or endoscopy, suffering with two or more of upper GI symptoms. The patients were instructed to undergo a strict GFD for a period of 1 month, under supervision of a dietitian. Glycemic levels were monitored by a continuous glucose monitoring device (CGM) for 2 weeks before, and for 2 weeks at the end of the GFD period. Upper GI symptoms, general quality of life, anxiety and depression were assessed using standardized questionnaires. Blood samples were collected to assess glycaemia (Hb1Ac) and lipid profiles. Scintigraphy and videofluoroscopy were used to assess gastric emptying. Results Seven patients finished the study so far. They reported a significant improvement in nausea (p<0.05), sensation of fullness (p<0.01), bloating (p<0.01), feeling of excessive fullness after meals (p<0.01) and having stomach visibly larger after meals (p<0.01). 5 out of the 7 patients reported an improvement in general quality of life, based on PAGI-QOL (Patient Assessment of Upper Gastrointestinal Disorders – Quality of Life), and decreased anxiety levels (HADS, Hospital Anxiety and Depression Score). There was no significant change in mean glucose level, time in target, glucose variance and HbA1c levels after GFD. However, there was a trend for less time spent in hypoglycemia, namely in those patients who experienced frequent hypoglycemia prior to GFD. Overall, there was no change in serum lipid profile or gastric emptying. Conclusions One month of GFD improved dyspepsia-like symptoms, general quality of life and anxiety levels in T1D patients without concomitant celiac disease. GFD also improved the blood glucose management of patients with frequent hypoglycemia. Thus, this dietary intervention appears to improve upper GI symptoms in T1D patients but the results need to be replicated in a larger patient cohort. Funding Agencies CIHR


Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 502-P
Author(s):  
ALEXANDRA L. MARLOW ◽  
BRUCE R. KING ◽  
SHAUN E. JOHNSON ◽  
SABRINA K. BINKOWSKI ◽  
JAN FAIRCHILD ◽  
...  

2017 ◽  
Vol 7 (1) ◽  
pp. e239-e239 ◽  
Author(s):  
J G Nunes-Silva ◽  
V S Nunes ◽  
R P Schwartz ◽  
S MLSS Trecco ◽  
D Evazian ◽  
...  

Bone ◽  
2008 ◽  
Vol 43 (2) ◽  
pp. 322-326 ◽  
Author(s):  
Giuliana Valerio ◽  
Raffaella Spadaro ◽  
Dario Iafusco ◽  
Francesca Lombardi ◽  
Antonio del Puente ◽  
...  

Author(s):  
Vi Lier Goh ◽  
D. Elizabeth Estrada ◽  
Trudy Lerer ◽  
Fabiola Balarezo ◽  
Francisco A. Sylvester

Sign in / Sign up

Export Citation Format

Share Document